Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa vs Darbepoetin alfa in Chemotherapy-Induced Anemia
NCT00315484Phase 4Completed
- Sponsor
- Ortho Biotech Inc.
- Start
- Feb 2003
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 4 trial of epoetin alfa, sponsored by Ortho Biotech Inc.. Started Feb 2003; status: completed.
02
Drugs
epoetin alfa
Beyond the preview
Go deeper on NCT00315484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315484.